Popular Resources

Jonathan L Thigpen

Headshot: Jonathan L Thigpen

Assistant Professor - Clinical and Administrative Sciences, School of Pharmacy

Academia and Research Fellowship - Duquesne University, Pittsburgh, PA, 2014
Pharmacoepidemiology Fellowship - University of Alabama at Birmingham, Birmingham, AL, 2013
Doctor of Pharmacy - Samford University, Birmingham, AL, 2011
Research Interests
Public Health, Health Disparities, Pharmacoepidemiology, Anticoagulation, Cardiology
Aronis KN (co-first author), Thigpen JL (co-first author), Tripodis Y, Dillon C, Forster K, Henault L, Quinn EK, Berger PB, Limdi NA, Hylek EM. Paroxysmal atrial fibrillation and the hazards of under-treatment. Int J Cardiol. 2016 Jan 1;202:214-20. PubMed PMID: 26397414.

Nghia Nguyen, Sharon K. Park, Jonathan Thigpen, Insong Lee. Accessibility of insurance coverage policies for pharmacogenomics testing. ASHP Midyear 2015 (abstract).

Todd M. Brown, Aditi Shendre, Qi Yan, Jonathan Thigpen, Nianjun Liu, T. Mark Beasley, Charles E. Hill, Nita A. Limdi. Anticoagulation control, risk of overanticoagulation and major hemorrhage among warfarin users is influenced by race. Circulation. 2015; 132:A16445. AHA Scientific Sessions 2015 (abstract).

Limdi NA, Brown TM, Yan Q, Thigpen JL, Shendre A, Liu N, Hill CE, Arnett DK, Beasley TM. Race influences warfarin dose changes associated with genetic factors. Blood. 2015 May 29. PubMed PMID: 26024874.

Nita A. Limdi, Jonathan Thigpen, Darae Ko, Emily K Sisson, Georgios Tripodis, Lori E Henault, Peter B Berger, Elaine Hylek. Influence of Race on Presentation, Treatment, and Outcome among Patients with Atrial Fibrillation related Ischemic Stroke. Quality of Care and Outcomes Research 2015 (abstract).

Darae Ko, Jonathan Thigpen, Lori Henault, Emily Quinn, Yorghos Tripodis, Peter Berger, Nita Limdi, Elaine Hylek. Ischemic Stroke in Atrial Fibrillation: 30-day Outcomes and Factors Associated with Severity. Arteriosclerosis, Thrombosis, and Vascular Biology | Peripheral Vascular Disease Scientific Sessions 2015 (abstract).

Thigpen JL, Dillon C, Forster KB, Henault L, Quinn EK, Tripodis Y, Berger PB, Hylek EM, Limdi NA. Validity of International Classification of Disease Codes to Identify Ischemic Stroke and Intracranial Hemorrhage among Individuals with Associated Diagnosis of Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):8-14.

Jonathan L. Thigpen, Chrisly Dillon, Kristen Forster, Lori Henault, Emily K. Quinn, Georgios Tripodis, Peter B. Berger, Elaine M. Hylek, Nita A. Limdi.  Antithrombotic Use at Time of Incident Stroke among Individuals with Recent Atrial Fibrillation. AHA Scientific Sessions 2013 (abstract).

Thigpen JL, Limdi NA. Reversal of Oral Anticoagulation. Pharmacotherapy. 2013 Apr 18. PubMed PMID: 23606318; PubMed Central PMCID: PMC3800206.

Jonathan L. Thigpen, Chrisly Dillon, Kristen Forster, Lori Henault, Emily Kate Quinn, Georgios Tripodis, Peter B. Berger, Elaine Hylek, Nita A. Limdi. Using International Classification of Diseases Ninth Revision Codes Overestimates the Frequency of True Stroke. ACC Annual Meeting 2013 (abstract).

Jonathan L. Thigpen, Pharm.D., Qi Yan M.S., Nianjun Liu Ph.D., Mark Beasley Ph.D., Nita A. Limdi, Pharm.D., Ph.D. Racial differences in anticoagulation control and risk of hemorrhage among warfarin users. ACCP Annual Meeting 2012 (abstract).

Professional Affiliations & Memberships
AACP HD-CC Executive/Planning Committee
American Association of Colleges of Pharmacy
SNPhA (Chapter Advisor)
Rho Chi
MD Responds